XOMA Corp (XOMA)
XOMA Corp is a NASDAQ-listed common stock of a healthcare company focused on biotechnology royalty investments. Through its operating business, the company holds economic rights tied to future milestone and royalty payments from partnered therapeutic candidates, including assets in pre-commercial and commercial stages. Its portfolio spans early- to mid-stage clinical programs, primarily in Phase 1 and Phase 2, as well as late-stage clinical and marketed assets. XOMA also seeks to acquire milestone and royalty revenue streams linked to partnered development programs. The company was originally incorporated in 1981 and is based in Emeryville, California. It operated previously under the name XOMA Corporation and adopted the XOMA Royalty Corporation name in July 2024.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-XOMA
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
July 30, 2026
|
35.6x
|
7.7x
|
14.6x
|
710.2 M
|
—
|
14.6%
|
7.0%
|
-4.1
|
16.4%
|
34.1%
|
